key: cord-1017895-zsz3qhgx authors: Sharma, R. P.; Gautam, S.; Sharma, P.; Singh, R.; Sharma, H.; Parsoya, D.; Deba, F.; Bhomia, N.; Pal, N.; Potdar, V. A.; Yadav, P. D.; Gupta, N.; Bhandari, S.; Malhotra, B. title: Clinico epidemiological profile of Omicron variant of SARS CoV2 in Rajasthan date: 2022-02-13 journal: nan DOI: 10.1101/2022.02.11.22270698 sha: 4a4347b7e8f3bd445f5fbd58bc07256672d35d1f doc_id: 1017895 cord_uid: zsz3qhgx Background: Omicron a new variant of SARS COV2 was first detected in November 2021. This was believed to be highly transmissible and evade immunity as a result urgent need was felt to screen all positive, identify Omicron cases and isolate them to prevent spread of infection and study their clinico-epidemiological profile. Methodology: All positive cases detected in state of Rajasthan during November to January beginning were selected for next generation sequencing. Processing was done as per protocol on Ion Torrent S5 system for 1210 samples and bioinformatics analysis was done. Results: Among the 1210 samples tested 762(62.9%) were Delta/Delta like and other lineages, 291(24%) were Omicron and 157(12.9%) were invalid or repeat samples. Within a month the proportion of Delta and other variants was reversed, from zero omicron became 81% and delta and other variants 19%, initially all omicron cases were international travellers and their contacts but soon community transmission was seen. Majority of omicron patients were asymptomatic (56.7%) or had mild disease (33%), 9.2% had moderate symptoms and 2(0.7%) had severe disease requiring hospitalization, of which one (0.3%) died and rest (99.7%) recovered. History of vaccination was seen in 81.1%, of previous infection in 43.2%. Among the Omicron cases BA.1 (62.8%) was the predominant lineage followed by BA.2(23.7%) and B.1.529 (13.4%), however rising trends were seen initially for BA.1 and later for BA.2 also. Conclusion: In very short time Omicron has spread in community and has taken over the pre-existing Delta/Delta like and other lineages, it evades immunity, but the good part is most of the cases were asymptomatic or had mild disease and mortality rate was very low. Key words; SARSCoV2, NGS, Omicron other diverse Omicron sequences. 21L and 21K share 38 mutations but 21L has additional 27 mutations (with 12 unique mutations) and 21K has 20 more (6 unique deletion/ mutation), 21L lacks the SH69-and Sv70-deletions which lead to S gene drop out or SGTF which has been used a proxy marker for Omicron in Taq Path PCR kits (1). It's reported that Omicron spreads 70 times faster than the Delta variant and can evade the immunity provided by natural infection and vaccination due to the mutations which are known to increase transmission, immune escape and enhance binding affinity (2). Though the preliminary data suggest that the illness caused may be asymptomatic to mild disease. But the severity of disease due to Omicron variant remains questionable as many factors like immune status, age comorbid conditions etc may affect it and may vary in different regions. Omicron has been reported from various countries and now from many states of India too. It's predicted that very soon it will take over the delta strain and become the dominant strain. It's important is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted February 13, 2022. ; https://doi.org/10.1101/2022.02.11.22270698 doi: medRxiv preprint downloaded and visualised using Nextstrain Auspice (accessed on 05 th February 2022) web software. The first nine Omicron positive cases were seen in a family with history of travel to south Africa and their close contacts. The family of four international travellers reported negative at South Africa and at Dubai before arriving in India, on reaching Rajasthan they visited their relatives. One of the local relative developed mild symptoms and underwent SARS COV2 testing and was found positive which led to testing of the family, another four came positive (total 5) and on tracing their contact history, the international travellers were traced and tested positive (4). These international travellers had gone to a wedding and another of their four contacts who attended the wedding were then found positive. Eventually other members of local family, their driver with his family also became positive for Omicron. Thus affecting 19 persons in cluster earlier samples were of B.1.1.529 lineage and later cases were found to be BA.1. Another big cluster was reported from district jail of nine patients all were found to be BA.2 positive and had mild symptoms. Among the 291 omicron cases 45 (15.4%) had history of international travel, 33 (11.3%) had history of national travel, 68(23.4%) were the contacts of known positive case. No history of contact or travel was obtained in 145 (49.8%) patients (Table-1 ). Among international travellers' maximum were from United Arab Emirates (UAE-24.4%) ( Table-2 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint Positivity for Omicron and other variants is given in table 3, in very short time Omicron rose from 0% to 81% overtaking Delta and Delta like variants. Initially the B.1.1.529 lineage was 100% but later both BA.1 and BA.2 emerged and BA.1 was the most predominant but BA.2 was found to be increasing each week. Highest positivity (68 %) was seen in 19-to-59-year age group, 17.1% positivity was seen in paediatric age group also (Table -4 ) higher positivity was seen in males (56.7%) than females (43.2%). Highest positivity for Omicron was found in Jaipur followed by Ajmer and Udaipur (Table-1) , Majority, 56.7% of patients were asymptomatic, 33% had mild disease (sore throat and myalgia) 9.6% had moderate disease/symptoms (fever, myalgia, cough, loss of taste and smell etc), 2(0.7%) patients, of more than 60 years old with multiple comorbidities developed respiratory distress and had to be hospitalised and required oxygen, one of them recovered while the other died in 7 days after illness. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint Time elapsed between vaccination and RT PCR positivity is given to figure 3, in majority (77.3%) of cases it was less than six months. Majority (70.3 %) of patients had taken Covishield, 20.9 % Covaxin, 6.6% Pfizer and 2.2 % Astra Zeneca and 126 (43.2%) patients had history of past infection in last six months. The study was approved by ethical committee of SMS Medical College Jaipur. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was first isolated from Wuhan, China in December 2019 (4). Soon the virus spread worldwide, and pandemic was declared by World Health Organization in March 2020. Since than due to many mutations various variants have emerged and caused various waves of infection. The second wave in India was caused by Delta variant which caused high morbidity and mortality, increase in number of hospitalisations, high requirement for oxygen and many cases of mucormycosis too. With the emergence of Omicron in South Africa, the concern was its effect on Indian population. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted February 13, 2022. ; https://doi.org/10.1101/2022.02.11.22270698 doi: medRxiv preprint We found first cluster of Omicron in a family of four returning from South Africa and their contacts in 1 st week of December which in turn infected 11more cases at Jaipur from their family, their staff, and his family too, later four more from Sikar who had come to attend a wedding in Jaipur, initial cases were of B.1.1.529 lineage while in later contacts BA.1 lineage emerged (5) . In our study only 15.4% had history of international and 11.3% of travel in India,23.4% were their contacts, but most importantly 49.8% cases had no history of travel or contact this indicated that community transmission had occurred by late December 2021 to early January 2022.Even another study from Delhi reported community transmission by early January (6) . The transmission history stresses the need for social distancing, use of mask and sanitizers and limiting the numbers in public gatherings. In our study majority of patients were asymptomatic (56.7%) or had mild disease (33%), only 28(9.6%) had moderate disease and only two (0.7%) patients had severe disease requiring hospitalisation. No difference was found in clinical profile of different lineages of Omicron. Majority recovered in seven days' time except one person who succumbed to death. Though as part of facility quarantine the international travellers and their contacts were initially admitted in designated area of the hospital. As per studies from Gauteng, South Africa only 4.9% case were admitted in hospital in fourth wave which was due to Omicron as compared to 18.9% and 13.7% in third and second waves which were due to Delta and other variants and 28.8% admitted cases in fourth wave had severe disease as compared to 60.1% and 66.9% in third and second waves (7) . As per the South African study the proportion of cases admitted in Omicron dominated wave were lower than Delta dominated wave and the sever cases were lower too. However, a study from Imperial college London reports that there is no evidence that the disease severity or hospitalisation due to Omicron are lower than Delta (8). Many factors like age, geographic area, immunisation coverage etc can affect severity of disease. Moreover, there is need for close monitoring of all hospitalised, especially severe cases and is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted February 13, 2022. ; https://doi.org/10.1101/2022.02.11.22270698 doi: medRxiv preprint deaths during the Omicron driven third wave in India to understand the clinical and public health implication of the new variant. Omicron is said to be more transmissible than the delta; the scare is that there will be high positivity. The Omicron poses 5.4 times higher risk of reinfection than Delta and the distribution by age, region and ethnicity may also be different in Omicron. Various modelling groups have predicted that SARS CoV2 infections will reach an unprecedented peak in next one to two months and may reach 35 million per day which is triple of the delta wave, its estimated that infection-hospitalisation rate may be 90-96 per cent lower for omicron as compared to delta, and the infection-fatality rate will also be 97-99 per cent lower for the same comparison (9,10,11). Omicron has affected more than 140 countries worldwide and most of the states in India and the numbers of Omicron have also risen to more than 10000. India reported 2.85 lakh new Covid-19 cases and 665 deaths in last 24 hours on 26 th January 2022 with 22.23 lakh active cases; the daily positivity rate was 16.16% with 93.2% recovery rate. Positivity was seen even when India has already administered 163.58 crore vaccine doses till now. In country like ours if only small percentage gets hospitalised and few die the sheer numbers will be high and will affect the health care systems. Moreover, the need for testing tracing and tracking and providing supportive treatment to mild cases, enhanced infection control measures, quarantine, isolation of infected staff, will greatly affect the health care systems. Since majority of patients were asymptomatic or had mild disease, it will be difficult to trace and track the positive persons as a result it will spread widely in community (2). In our study we found 23.7 % strains to belonged to BA.2, this lineage doesn't have the SH69and Sv70-deletions which lead to S gene drop out or SGTF which has been used a proxy marker for Omicron in Taq Path PCR kits therefore using such kits may not detect Omicron moreover we found a rising trend in BA.2 lineage in our samples hence use of these kits can give false negative for Omicron (7, 12) . However, a new kit Omisure (TATA Medical and is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted February 13, 2022. ; https://doi.org/10.1101/2022.02.11.22270698 doi: medRxiv preprint Diagnostics) validated by ICMR for Omicron detection may be used to detect omicron which will be particularly useful to identify if the hospitalised patient is omicron or not as with the increase in positivity all the positives cannot be sequenced anymore (13) . In our study 81.1 % of patients were fully vaccinated and 5.1 % were partially vaccinated, time elapsed in 77.3% cases was less than 6 months. Majority (70.3%) of patients had taken Covishield, 20.6% had taken Covaxin while only few had taken other vaccines abroad Pfizer (6.6%), AstraZeneca (2.2%). As per a serosurvey done in Rajasthan during November 2021-December 2021 we observed 85% to 94% population had neutralising antibodies against SARS COV2, even the nonvaccinated had seropositivity of 74% (unpublished data). The low severity observed in our cases may be due to the protective effect of the past vaccination or infection. However, Omicron has been reported to evade the immune response both due to vaccination and earlier infection too. As per a report from Imperial college London the vaccine effectiveness due to Omicron versus Delta variant after two doses of vaccine (AstraZeneca or Pfizer) was 0% and 20% and after booster dose was 55% and 80% respectively (8).As per the vaccine surveillance report from UK after 2 doses of the AstraZeneca vaccine, vaccine effectiveness against the Omicron was initially 45 to 50% but dropped to no effect after 20 weeks of second dose. Similarly, after 2 doses of Moderna or the Pfizer the efficacy reduced from 65% to 10 % by 25 weeks after 2 nd dose. However, after the additional booster dose the efficacy dropped from 65% to 25%-40% in 15 weeks, efficacy was better in younger age group than higher age and better in Delta than Omicron (14). An interesting observation in a study done at Pune demonstrated that substantial immune response was seen after omicron breakthrough infection against other variants. The Omicron infected persons sera could neutralise not only the Omicron, but also other variants of concern, including the most prevalent Delta variant thus reducing the chances of reinfection due to Delta and as a result replacing the Delta variant in the population. This stresses the urgent need to have an Omicron- is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted February 13, 2022. ; https://doi.org/10.1101/2022.02.11.22270698 doi: medRxiv preprint specific vaccine strategy. (15) . Though the virus is known to evade the immune response the severity of infection will be lower in the immunised person so it's important that the booster dose/ precautionary dose is taken timely. Moreover, it's suspected that non vaccinated may bear the brunt so aggressive drives should be there to vaccinate all. In nutshell as per our preliminary data the Omicron is highly transmissible; in very short time it has spread in the community and has overtaken the existing Delta strain. It causes mainly The authors declare no conflict of interest. The study was approved by the Institutional Ethics Committee of SMS Medical College Jaipur. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted February 13, 2022. ; https://doi.org/10.1101/2022.02.11.22270698 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted February 13, 2022. ; https://doi.org/10.1101/2022.02.11.22270698 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted February 13, 2022. ; https://doi.org/10.1101/2022.02.11.22270698 doi: medRxiv preprint Global Initiative on Sharing All Influenza Data (GISAID) 2020 Clade and lineage nomenclature aids in genomic epidemiology studies of active hCoV-19 viruses A new coronavirus associated with human respiratory disease in China The Indian SARS-CoV-2 Genomics Consortium (INSACOG). Detection of the omicron variant in international travelers and their family contacts in India Evidence of early community transmission of Omicron (B1.1.529) in Delhi-A city with very high seropositivity and past-exposure! medRxiv South Africa During the Omicron-Dominant Fourth Wave SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests | FDA COVID-19 vaccine surveillance report Week We acknowledge the support provided by Shree Vaibhav Galriya Principal Secretary